Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Langley

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Acta Dermato-Venereologica. Supplementum|December 3, 2005
New therapeutic targets in atopic eczemaRichard Langley
Canadian Family Physician Medecin De Famille Canadien|May 16, 2013
Dermacase. Can you identify this condition? Median canaliform nail dystrophyLesley Latham, Richard Langley
Journal of Cutaneous Medicine and Surgery|August 11, 2005
Safety and efficacy of tacrolimus ointment 0.1% (Protopic) in atopic dermatitis: a Canadian open-label multicenter studyJerry Tan, Richard Langley
Journal of Cutaneous Pathology|November 27, 2025
Deep Dermal and Subcutaneous Deposits in Thin Melanoma: A Cautionary TaleAngela Cheng, Jennette Gruchy, Ariel Burns, et al.
Journal of Cutaneous Medicine and Surgery|January 19, 2005
The use of alefacept in the treatment of psoriasisRichard Langley, Aditya K Gupta, Yves Poulin, et al.
Archives of Dermatology|June 18, 2003
An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasisMark Lebwohl, Enno Christophers, Richard Langley, et al.
Journal of Cutaneous Pathology|April 21, 2012
Scleromyxedema and the dermato-neuro syndrome: case report and review of the literatureKirsten E Fleming, Divya Virmani, Evelyn Sutton, et al.
Journal of Cutaneous Medicine and Surgery|January 19, 2005
Pathogenesis of psoriasis and current challengesAditya K Gupta, Richard Langley, Yves Poulin, et al.
Journal of Cutaneous Medicine and Surgery|April 25, 2006
Strategies for optimizing treatment with efalizumab in moderate to severe psoriasisKim A Papp, Vincent Ho, Richard Langley, et al.
The Journal of Dermatological Treatment|August 12, 2017
Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trialApril Armstrong, Luis Puig, Richard Langley, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Acta Dermato-Venereologica. Supplementum|December 3, 2005
New therapeutic targets in atopic eczemaRichard Langley
Canadian Family Physician Medecin De Famille Canadien|May 16, 2013
Dermacase. Can you identify this condition? Median canaliform nail dystrophyLesley Latham, Richard Langley
Journal of Cutaneous Medicine and Surgery|August 11, 2005
Safety and efficacy of tacrolimus ointment 0.1% (Protopic) in atopic dermatitis: a Canadian open-label multicenter studyJerry Tan, Richard Langley
Journal of Cutaneous Pathology|November 27, 2025
Deep Dermal and Subcutaneous Deposits in Thin Melanoma: A Cautionary TaleAngela Cheng, Jennette Gruchy, Ariel Burns, et al.
Journal of Cutaneous Medicine and Surgery|January 19, 2005
The use of alefacept in the treatment of psoriasisRichard Langley, Aditya K Gupta, Yves Poulin, et al.
Archives of Dermatology|June 18, 2003
An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasisMark Lebwohl, Enno Christophers, Richard Langley, et al.
Journal of Cutaneous Pathology|April 21, 2012
Scleromyxedema and the dermato-neuro syndrome: case report and review of the literatureKirsten E Fleming, Divya Virmani, Evelyn Sutton, et al.
Journal of Cutaneous Medicine and Surgery|January 19, 2005
Pathogenesis of psoriasis and current challengesAditya K Gupta, Richard Langley, Yves Poulin, et al.
Journal of Cutaneous Medicine and Surgery|April 25, 2006
Strategies for optimizing treatment with efalizumab in moderate to severe psoriasisKim A Papp, Vincent Ho, Richard Langley, et al.
The Journal of Dermatological Treatment|August 12, 2017
Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trialApril Armstrong, Luis Puig, Richard Langley, et al.
Pageof 2